Ann: Kyocera completes Progenza Due Diligence, page-12

As TILLI has said, you make a good point bioqld about Kyocera not proceeding past DD if there were issues with Progenza.

The question now is whether RGS' very weak financial position will force it to grant an exclusive licence to Kyocera for Progenza in Japan at a rock bottom price.

I guess we should know soon enough, and I must admit things are looking somewhat brighter than they were just a few months ago. So, while my holding is a bit lighter than it was in February, today's announcement has moved my sentiment from Sell to Hold, for the time being.

zeno9